Effect of tranexamic acid (AMCA) in menorrhagia with intrauterine contraceptive devices.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000933:Antifibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006452:Hemoglobinometry; D006801:Humans; D007434:Intrauterine Devices / Q000009:adverse effects*; D008595:Menorrhagia / Q000188:drug therapy*; D010298:Parity; D010919:Placebos; D010958:Plasminogen; D011247:Pregnancy
D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D010919:Placebos; D010958:Plasminogen